SOURCE: Plandai Biotechnology, Inc.

July 13, 2015 09:00 ET

Plandai Biotechnology, Inc. Continues to Deliver Green Tea Extract to USN

GOODYEAR, AZ--(Marketwired - July 13, 2015) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company”), producer of the highly bioavailable Phytofare® Catechin Complex, today announced that Azochem Laboratories, a contract manufacturer for USN in South Africa, placed the second USN related purchase order for the Company’s Phytofare® Catechin Complex.

Callum Cottrell-Duffield, Vice President of Sales and Marketing for Plandaí, said, "As part of our exclusive 3-year agreement with USN to supply USN’s contract manufacturers with our flagship green tea extract, our product will be represented on shelves worldwide. We take seriously our contractual requirements to fill orders to USN quickly and efficiently as possible and handle all of the logistic components that come with sales to USN both now and in the future."

USN is a global health and nutrition supplement brand that sells products in more than 50 countries and on four continents. USN was founded in South Africa 15 years ago. All of USN’s products are formulated with the backing of extensive research and scientific findings, as well as clinical trials to ensure efficacy and safety.

The exclusive agreement between Plandaí and USN will allow USN to control the input costs around production, while enhancing product efficacy by replacing the generic green tea extracts it now uses in its extensive lineup of innovative and market-leading products, with the clinically proven highly bioavailable Phytofare® Catechin Complex.

About Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc. and its subsidiaries develop highly phyto-available extracts. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company’s products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.

Contact Information

  • Contact:
    Marlin Molinaro
    Marmel Communications, LLC
    Phone: (702) 434-8692
    Email: mmolinarofc@aol.com